TxCell presents a series of new scientific data at the ISCT 2016 Annual Meeting

Friday, May 27, 2016

TxCell SA FR0010127662 TXCL a biotechnology company developing innovative personalized cellular immunotherapies using regulatory T cells Treg to treat severe chronic inflammatory and autoimmune diseases today announces the presentation of novel mechanism of action data for its lead drug candidate O..

Shire Receives Positive CHMP Opinion in Europe for Revestive Teduglutide for Paediatric Patients with Short Bowel Syndrome

Friday, May 27, 2016

Shire plc today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP adopted a positive opinion recommending the extension of the approval of Revestive teduglutide 5 mg powder and solvent for solution for injection in paediatric patients aged one to 1..

Shire Receives Positive CHMP Opinion in Europe for Revestive Teduglutide for Paediatric Patients with Short Bowel Syndrome

Friday, May 27, 2016 PR Newswire

ZUG Switzerland May 27 2016 PRNewswire Shire plc LSE SHP NASDAQ SHPGtoday announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP adopted a positive opinion recommending the extension of the approval of Revestive teduglutide 5 mg powder and solvent f..

Edison Issues Reinitiation on Hutchison China MediTech

Friday, May 27, 2016 PR Newswire

LONDON May 27 2016 PRNewswire Hutchison China MediTech ChiMed HCM is an innovative biopharma company focused on the highly lucrative global oncology and immunology markets HCM has built a substantial pipeline of potential firstinclass or bestinclass tyrosine kinase inhibitor TKI drugs some of wh..

Intellipharmaceutics Announces Pricing of 52 Million Public Offering of Common Shares and Warrants

Friday, May 27, 2016 GLOBE NEWSWIRE

TORONTO May 27 2016 GLOBE NEWSWIRE Intellipharmaceutics International Inc NASDAQIPCI TSXI a pharmaceutical company specializing in the research development and manufacture of novel and generic controlledrelease and targetedrelease oral solid dosage drugs today announced the pricing of an under..

SIPPET an international randomized study reports 87 higher incidence of inhibitors with recombinant factor VIII in patients with severe hemophilia A

Thursday, May 26, 2016 PR Newswire

MILAN May 26 2016 PRNewswire SIPPET a study which involved 42 centers in 14 countries in Europe North and South America Africa and Asia was designed to definitively settle the longdebated question whether factor VIII concentrates from different sources plasmaderived containing VWF or recombinant t..

ContraVir Pharmaceuticals to Present at 2016 Marcum MicroCap Conference

Thursday, May 26, 2016 PR Newswire

EDISON NJ May 26 2016 PRNewswire ContraVir Pharmaceuticals Inc NASDAQCTRV a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies announced today that it will present at The 2016 Marcum MicroCap Conference being held June 12 2016 at the Grand Hy..

Lannett To Voluntarily Pay Down 50 Million Of 12 Senior Notes

Thursday, May 26, 2016 PR Newswire

PHILADELPHIA May 26 2016 PRNewswire Lannett Company Inc NYSE LCI today announced that it expects to repurchase 50 million of the 250 million aggregate principal amount of the 12 Senior Notes due in 2023 in open market transactions The company intends to complete the repurchase today BMO Capital ..

Lannett To Voluntarily Pay Down 50 Million Of 12 Senior Notes

Thursday, May 26, 2016 PR Newswire

PHILADELPHIA May 26 2016 PRNewswire Lannett Company Inc NYSE LCI today announced that it expects to repurchase 50 million of the 250 million aggregate principal amount of the 12 Senior Notes due in 2023 in open market transactions The company intends to complete the repurchase today BMO Capital ..

BD Expands its Portfolio of EasytoUse Cell Sorters with Introduction of BD FACSMelody System

Thursday, May 26, 2016 PR Newswire

FRANKLIN LAKES NJ May 26 2016 PRNewswire BD Becton Dickinson and Company NYSE BDX a leading global medical technology company continues to reinforce its commitment to making flow cytometry easier and more affordable with the introduction of its newest cell sorter the BD FACSMelody system Built for..

Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller

Thursday, May 26, 2016 PR Newswire

LAVAL Quebec May 26 2016 PRNewswire Valeant Pharmaceuticals International Inc NYSE VRX TSX VRX Valeant today announced that Sam Eldessouky has been named Senior Vice President and Corporate Controller effective May 31 2016 Mr Eldessouky who has over 20 years of experience in accounting and finance..

Sorrento Therapeutics to Present at the Jefferies 2016 Healthcare Conference

Thursday, May 26, 2016 PR Newswire

SAN DIEGO May 26 2016 PRNewswire Sorrento Therapeutics Inc NASDAQ SRNE Sorrento an antibodycentric clinicalstage biopharmaceutical company developing new treatments for cancer and other unmet medical needs announced today that Dr Henry Ji President and CEO will present at the Jefferies 2016 Health..

AcelRx Pharmaceuticals Presents Results from Phase 3 Study of ARX04 following Ambulatory Abdominal Surgeries at Euroanaesthesia

Thursday, May 26, 2016 PR Newswire

REDWOOD CITY Calif May 26 2016 PRNewswire AcelRx Pharmaceuticals Inc NASDAQ ACRX today announced that the Company and its investigators will be presenting Phase 3 SAP301 study results at Euroanaesthesia 2016 which is taking place in London UK on May 2830 2016 In the SAP301 study patients with mode..

Soligenix to Present at the 2016 Marcum MicroCap Conference

Thursday, May 26, 2016 PR Newswire

PRINCETON NJ May 26 2016 PRNewswire Soligenix Inc OTCQB SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today thatPresident and Chief Executive Officer Chris..

Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property

Thursday, May 26, 2016 PR Newswire

CRANBURY NJ May 26 2016 PRNewswire Palatin Technologies Inc NYSE MKT PTN a biopharmaceutical company developing targeted receptorspecific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential announced that the United States Patent and Tra..

AbbVie to Present at the Jefferies 2016 Healthcare Conference

Thursday, May 26, 2016 PR Newswire

NORTH CHICAGO Ill May 26 2016 PRNewswire AbbVie NYSE ABBV will participate in the Jefferies 2016 Healthcare Conference on Wednesday June 8 2016 Bill Chase executive vice president and chief financial officer will participate in a question and answer session at 730 am Central time A live audio we..

Tocagen Announces Presentations at the 2016 BIO International Convention and Boston CEO Conference

Thursday, May 26, 2016 PR Newswire

SAN DIEGO May 26 2016 PRNewswire Tocagen Inc a clinicalstage cancerselective gene therapy company today announced members of the companys management team will participate on a panel discussing the intersection of immuno viral and genebased therapies for cancer treatment and present a corporate ove..

Genoa a QoL Healthcare Company Opens 300th Pharmacy within Community Mental Health Centers

Thursday, May 26, 2016 PR Newswire

TUKWILA Wash May 26 2016 PRNewswire Genoa a QoL Healthcare Company Genoa announced today the opening of its 300th pharmacy in Tamarac Fla within Henderson Behavioral Health Henderson Genoas unique onsite pharmacy model helps overcome the barriers many people with mental illness face by providing m..

Armetheon Completes Acquisition of Budiodarone and Plans Development for the Treatment of Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators

Thursday, May 26, 2016 PR Newswire

MILPITAS Calif May 26 2016 PRNewswire Armetheon Inc a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases today announced that it has completed the acquisition of budiodarone an antiarrhythmic agent in Phase 2 development In a previous Phase 2 study P..

Genomic Health Announces Presentation of Seven Oncotype DX Studies at the 2016 American Society of Clinical Oncology Annual Meeting Including Additional Prospective Outcomes Analysis

Thursday, May 26, 2016 PR Newswire

REDWOOD CITY Calif May 26 2016 PRNewswire Genomic Health Inc Nasdaq GHDX today announced that the company will present results from seven Oncotype DX studies at the 2016 American Society of Clinical Oncology ASCO Annual Meeting which will take place June 37 at McCormick Place in Chicago The result..

TOP